When Actavis took a new medical treatment to market, Eli Lilly thought it looked familiar. They had their own product that had been patented and the one from Actavis was only a slight variation. In this episode we explore the issues that arose surrounding intellectual property law and consider the wider implications when it comes to tightening or loosening the European patent system. Music from bensound.com
Share this post
Actavis UK Ltd v Eli Lilly and Company [2017] UKSC 48
uklawweekly.substack.com
Actavis UK Ltd v Eli Lilly and Company [2017] UKSC 48
Oct 30, 2017
Listen on
Substack App
RSS Feed
Recent Episodes
Actavis UK Ltd v Eli Lilly and Company [2017] UKSC 48